Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, is not more effective than remdesivir alone for treating ...
Jan 28, 2022
0
69